AMED: Amedisys, Inc. - Summary | Jitta

Amedisys, Inc.

NASDAQ:AMED

Price
$293.89
Loss Chance
43.6%
6.80JITTA SCORE
95.12%Over Jitta Line
Jitta Ranking
59 / 936
731 / 4,289
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (77)
Recent Business Performance (82)
Financial Strength (87)
Return to Shareholders (47)
Competitive Advantage (73)
Jitta Signs
Revenue and EarningConsistent Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Cash Conversion CycleLess than 60 days
Key Stats
Jitta Score
Jitta Line
6.80
95.12%
2.30
333.08%
Health Care Services
5.43
74.55%
6.03
25.98%
8.34
67.78%
COMPANY DESCRIPTION
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer’s, or cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 18, 2020, the company owned and operated 479 care centers in 38 states and the District of Columbia. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.